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Protein ﬁbrillation is ﬁrst and foremost a structural phenomenon. Adequate structural investigation
of the central conformational individuals of the ﬁbrillation process is however exceedingly difﬁcult.
This is due to the nature of the process, which may be described as a dynamically evolving equilib-
rium between a large number of structural species. These are furthermore of highly diverging sizes
and present in very uneven amounts and timeframes. Different structural methods have different
strengths and limitations. These, and in particular recent advances within solution analysis of the
undisturbed equilibrium using small angle X-ray scattering, are reviewed here.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Protein ﬁbrillation is ﬁrst and foremost a structure related
phenomenon. Not only are ﬁbrillar structures exceedingly fasci-
nating formations of an almost esthetically pleasing overall con-
struction. Also, the entire onset of the ﬁbrillation process is
deﬁned (perhaps with bacterial functional ﬁbrils as a prominent
exception [1]) via refolding of native proteins into temporary
conformations of very limited stability, ultimately leading to sub-
sequent formation of suprastructures of high complexity (Fig. 1).
The suprastructural formations potentially include several levels
of tangling of protoﬁlaments and -ﬁbrils, often resulting in heter-
ogeneous populations of different ﬁbril morphologies [2] (Fig. 2),
which may further repack over time. Between the initial destabli-
sation of the native structure and the ﬁnal tangling of the
micrometer long mature structures, lies sequential addition of
the individual ﬁbril building blocks, which one by one must
add to the growing ﬁbrils. Fibril building blocks may be of mono-chemical Societies. Published by E
yloid b; AFM, atomic force
microscopy; EOM, ensemble
spectroscopy; NMR, nuclear
gle neutron scattering; SAS,
ttering; ss-NMR, solid-state
py; ThT, thioﬂavin T; TTR,or oligomeric nature (e.g. [3,4]), certainly with a markedly mod-
iﬁed overall conformation as opposed to the native state,
although this overall conformation may be of a less well-deﬁned
nature than the typical stable protein structures, which are
known, e.g. from the enzyme world. The structural nature of
such a building block and structural details of the individual
interactions between the millions of protomers of a single pro-
tein ﬁbril are important for achieving an understanding of the ﬁ-
bril elongation process and for potential modiﬁcation, control or
inhibition of the process. This has obvious relevance in treatment
of amyloid disease, but if adequately controlled, such knowledge
may also be of potential relevance in designing functional nano-
structures with desired surface properties from biological mate-
rial. A detailed structural insight into the destablisation of the
native fold in the initial stages of the ﬁbrillation process is cen-
tral for future development of inhibitors of ﬁbrillation, aiming at
prophylactic treatment of the associated amyloid diseases, or at
stabilisation of industrially produced proteins, e.g. in the phar-
maceutical industry. Importantly, several studies indicate that
speciﬁc oligomeric structures, formed on- or off-pathway during
ﬁbrillation and signiﬁcantly smaller than mature ﬁbrils, may be
the primary cause of the cytotoxicity (e.g. [5–7]), associated with
several engraving diseases. There is an obvious interest in reveal-
ing the structural speciﬁcities of such compounds, again to en-
able rational drug design.
Hence, structural insight is not only key to understanding
the ﬁbrillation phenomenon, it is also a prerequisite for thelsevier B.V. All rights reserved.
Fig. 1. Illustration of the many equilibria involved in the ﬁbrillation process using insulin as an example. Starting from a native R6 hexameric form in equilibrium with dimer
and monomer states (all built from pdb id 1ev6) a (partially) un-/refolded state is formed. The state is marked by a ? since no adequate structural information exists at
present. Models of an oligomeric state of insulin and the corresponding mature ﬁbrils were obtained by SAXS [4]. The oligomers are presumed building blocks forming the
protoﬁlaments, which then intertwine to form the mature ﬁbrils. The mature ﬁbrils shown in this scheme consist of three intertwining protoﬁlaments, but often mixtures of
different morphologies co-exist.
Fig. 2. Examples of models of mature ﬁbrils, obtained from different methods. Top left: Electron micrographs and reconstructions of individual Ab1–40 ﬁbrils. (Selected panels
are reprinted from J. Mol. Biol. Meinhardt, J., Sachse, C., Hortschansky, P., Grigorieff, N., and Fandrich, M. ‘‘Abeta(1–40) ﬁbril polymorphism implies diverse interaction
patterns in amyloid ﬁbrils” pp. 869–877  2009 with permission from Elsevier.) Right: Models of glucagon ﬁbrils based on SAXS. The two different structures are formed at
different concentrations. The models are built from building blocks of high-resolution native glucagon and ﬁtted to the SAXS-data. (Reprinted from J. Mol. Biol., 387, Oliveira,
C.L.P., Behrens, M.A., Pedersen, J.S., Erlacher, K., Otzen, D.E., and Pedersen, J.S., ‘‘A SAXS study of glucagon ﬁbrillation”, pp. 146–161,  2009 with permission from Elsevier.)
Bottom: SAXS based model of three repeating units of mature insulin ﬁbrils [4]. The model of one repeating unit is an average of several individually calculated ab initio bead
models, hence the models are objective.
A.E. Langkilde, B. Vestergaard / FEBS Letters 583 (2009) 2600–2609 2601century-long awaited breakthrough in treatment of amyloid dis-
eases, and also an important factor to meet the increasing demand
for protein stabilizers in the growing protein-based industry. All of
this said, the associated great basic scientiﬁc interest should beemphasized. Fibrillation has been suggested to be a generic prop-
erty of all proteins [8], yet is only observed in speciﬁc cases. An in-
creased comprehension of structural phenomena in ﬁbrillation is
inherently related to an improved understanding of protein fold
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knowledge about proteins.
Even so, after a century of constantly increasing focus on ﬁbril-
lation we do not have an adequate structural understanding of the
phenomenon. To a large extent, this is due to the nature of the
ﬁbrillation process, most often including a large number of co-
existing structural species of greatly diverging sizes – a situation,
which complicates almost any type of structural investigation.
Add to this the sensitivity of the ﬁbrillating systems to any changes
of experimental/external conditions, and the result is an exten-
sively challenging research ﬁeld, of utmost importance.
Several widespread techniques are being utilized in the study of
the ﬁbrillation process and the species involved. Some of these
techniques only indirectly add structural information to our under-
standing of the process. A prominent example concerns the usage
of ﬁbril-speciﬁc ﬂuorescent probes, which to some extent is the
golden standard for detection and characterization of the ﬁbrilla-
tion process, and has been used extensively throughout the com-
munity for half a decade [9]. However, without atomic resolution
information about the molecular interactions between ﬁbrils and
probes, we cannot adequately analyse and interpret ﬂuorescence
data, let alone rationally design and develop improved probes withFig. 3. Examples of raw data types, from methods applied in the study of amyloid structu
study of insulin ﬁbrillation [4]. From top to bottom, data is collected at increasing time p
s = 4psin h/k; 2h is the scattering angle and k is the X-ray wavelength. Each data curve is tr
particular case ﬁtting was obtained to approximately 20 Å resolution, but resolution in S
diffraction pattern from the GNNQQNY peptides (courtesy of A.Ø. Madsen and D. Eisenbe
conditions (pH 1.6) (V. Fodera and B. Vestergaard, unpublished data). Insets show how
crystals, hence peptides (top) pack in very small unit cells and insulin (bottom) packs i
scattering from ice on the surface of crystals is evident. The diffraction extends to 1.8 Å (G
diffraction data from partially aligned insulin ﬁbrils (adapted from [4]). The most domina
are visible on the equator (E). Right, bottom: time-evolution of far-UV CD signals from ﬁ
Relini, A., Librizzi, F., Militello, V., Gliozzi, A., and Leone, M., ‘‘Amyloid ﬁbrils formation an
from Elsevier.)altered speciﬁcity, e.g. for early oligomers or particular ﬁbrillar
morphologies.
This minireview aims at highlighting some of the many recent
impressive advances within structural analysis of protein ﬁbrilla-
tion and at discussing aspects of the current exciting development
within the ﬁeld.
2. Structural ﬁngerprints – the cross-b pattern
Several deﬁnitions of the term ‘amyloid’ are used. One of the
less restrictive, based on biophysical characteristics, is ‘a polypep-
tide, which upon polymerisation exhibits the characteristical cross-b
pattern’, as identiﬁed by X-ray ﬁber diffraction studies. Fiber dif-
fraction provides spatial information of frequently occurring dis-
tances in the structures. The diffraction patterns (Fig. 3, top
right) from (partially) aligned amyloid ﬁbrils display very strong
intensities, which in real space correspond to distances of 4.7 Å
and approximately 10–11 Å, the former in the meridian plane,
the latter in the meridonal plane, hence relating to typical dis-
tances perpendicular and parallel to the long axis of the ﬁbrils,
respectively [10]. These distances are identical to the typical dis-
tances seen in a b-sheet sandwich, hence protein ﬁbrils all seemre. Left: Background subtracted radially averaged SAXS data curves from the kinetic
oints throughout ﬁbrillation and the scattering intensity I is plotted as a function of
anslated to ease visualization. The nominal resolution is indicated as d = 2p/s. In this
AXS data often extends to medium resolution (sub-nanometer). Middle top: Crystal
rg). Middle bottom: crystal diffraction pattern from insulin at ﬁbrillation-promoting
the spacing between reﬂections differ depending on the size of the unit cells of the
n a relatively larger unit cell. In the diffraction image from insulin crystals, diffuse
NNQQNY peptides) and approximately 1.9 Å (insulin), respectively. Right, top: Fiber
nt reﬂection is at 4.8 Å at the meridian (M), and weaker signals at 10.5, 14.5 and 30 Å
brillating concanavalin A. (Reprinted from Biophys. Chem., 125, Vetri, V. Canale, C.,
d amorphous aggregation in concanavalin A”, pp. 184–190,  2006 with permission
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extensive b-sheets with individual b-strands perpendicular to the
ﬁbril axis (Fig. 4). Existence of large proportions of b-strands in
ﬁbrillated protein is easily conﬁrmed, e.g. using Fourier-transform
infrared spectroscopy (FTIR) or circular dichroism (CD). This fea-
ture seems to be the main structural feature of all amyloid ﬁbrils,
irrespective of the native protein fold of individual proteins. Hence,
signiﬁcant refolding of the proteins is a prerequisite for ﬁbrillation
in most cases.
Quasi high-resolution features have been modelled when inter-
preting ﬁber diffraction data, often in combination with comple-
mentary high-resolution structural information. Recent examples
include the analysis of short peptide-based ﬁbers [11,12] or longer
protein fragments [13] in a powerful combination with solid-state
NMR (ss-NMR) (see later section). This concept would become
even more promising by including structural information from
additional complementary methods, e.g. from small angle X-ray
scattering (SAXS) and X-ray crystallography. This would further
diminish the inherent uncertainties when modelling structure
based on underdetermined data.
3. Speciﬁcations of individual structural states
The cross-b ﬁbrils are the end product of the amyloid ﬁbrillation
process. The ﬁbrils are micrometer long, predominantly un-Fig. 4. Examples of results from high-resolution methods. Crystal structures of
peptides GNNQQNY (a, b) and VEALYL (c, d). A few strands of the dry-zipper are
illustrated in side and top view. The b-sheets are either parallel (GNNQQNY) or anti-
parallel (VEALYL). The peptide ﬁgures were produced using PyMol [86] based on
deposited structures (pdb id 1yjp [49] and 2omq [50], respectively). A model of TTR
ﬁbrils (e) (reprinted from [63]) based on the crystal structure of the native protein
and solution NMR experiments on ﬁbrillated TTR is shown. Colors indicate relative
protection factors obtained through H/D exchange experiments.branched aggregates, often consisting of several intertwining pro-
toﬁbrils. The formation mechanism is heavily debated (e.g. [14–
16]) but all agree that several structural states appear during the
process. Fig. 1 shows an example of a number of equilibria, in-
volved with insulin ﬁbrillation. One may consider the starting
point of ﬁbrillation as being divided into two distinct structural
classes: those where the monomeric native protein adopts a glob-
ular fold (as monomers or in some cases, such as insulin, predom-
inantly as native oligomers that must ﬁrst be disrupted), and those
where the protein is natively unfolded (classical examples being a-
synuclein, the amyloid b (Ab) peptide and amylin). In both cases
the monomeric protein partly refolds into a non-native structure
of low thermodynamic stability. At present, no high-resolution
structural information exists from a signiﬁcantly refolded mono-
meric ﬁbrillation precursor, although several destablised struc-
tures are described. From this structural equilibrium, an
important component for the understanding of ﬁbrillation – the
nucleus – may form. The nucleus is per deﬁnition the thermody-
namically least favorable species on the ﬁbrillation pathway. It is
believed to consist of a critical number of associated un/refolded
protomers, and upon formation of the nucleus the elongation
phase of ﬁbrillation initiates, during which either non-native
monomers or oligomers associate to form the protoﬁbrils. The
interest in the nucleus structure derives ﬁrstly from the basic
assumption that the nucleus is the smallest possible unit that de-
ﬁnes the repeating structure of the whole ﬁbril. Hence, the struc-
tural features of this particular species are the exact structural
features that deﬁne the entire ﬁbril structure, and if the nucleus
is adequately structurally described, so is the ﬁbril. But the large
interest in the nucleus also relates to a number of studies, which
indicate that oligomeric preﬁbrillar structures, and not the mature
ﬁbrils, are the cause of cytotoxicity (e.g. [6]). Whether such toxic
oligomeric structures are on- or off-pathway is not clear, hence
the toxic species may or may not be identical to the nucleus. The
ﬁnal structural assembly can include longitudinal intertwining or
lateral assembly of individual elongated protoﬁbrils, with varying
levels of complexity. Often, several ﬁbril morphologies co-exist in
solution [17–19]. The molecular weights of individual species cov-
er a range from Da (peptides) to MDa (repeating units of mature ﬁ-
brils), and most species co-exist in equilibrium. Truly a challenging
system for analysis.4. Direct visualization of ﬁbrils and oligomers
Electron microscopy (EM) is traditionally considered a low-res-
olution method, but has the huge advantage of being a direct
method, hence avoiding the phase-problem inherent to scattering
and diffraction techniques. Both transmission and scanning EM
has been used extensively for low-resolution characterization
and visualization of mature protein ﬁbrils. For biological specimens
cryo-EM greatly improves resolution, and impressive results have
been obtained [2,17]. Reconstructions reveal the level of branching,
helical pitch of individual ﬁbrils, number and overall dimensions of
protoﬁbrils/-ﬁlaments, and more recently with the improved reso-
lution even the ﬁrst traces of the main-chain are now appearing
[20]. The latter achievement has been made possible by recent ad-
vances in reconstruction methods and hardware. Three dimen-
sional (3-D) reconstruction may greatly beneﬁt from averaging
over the symmetric particles, and can be performed from individ-
ual subpopulations within cryo-graphs [17,20], based on either
subjective or objective (software based) selection [21]. In fact,
since individual ﬁbrils have a high number of structural repeats,
it is possible to perform averaging over a single ﬁbril. This has been
used to reconstruct as many as 12 different ﬁbril morphologies
from one individual sample of Ab(1–40) [22], (Fig. 2, top left),
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morphologies, perhaps guided by local variations in protein con-
centration or other slight deviations. Even higher-resolution imag-
ing may be obtained but assumingly requires signiﬁcantly
increased control over the ﬁbrillation process in order to generate
more homogeneous samples, which still is preferable over the
selection processes after data collection or, which alternatively
supports the effort. The method is thus ideal for the visualization
of mature ﬁbrils with great promise for higher-resolution recon-
structions in the near future. Electron microscopy has also been
used to visualize isolated apparent off-pathway protoﬁbrillar
structures, e.g. the annular cold-induced a-synuclein oligomers,
particularly visible among familial mutant A53T preparations
(Fig. 5, right), or corresponding mixtures of tubular, annular and
spherical structures in wild-type and familial mutant A30P prepa-
rations [23].
In contrast to the averaging methodologies often used in cryo-
EM reconstructions, scanning tunneling electron microscopy
(STEM) and atomic force microscopy (AFM) produce single particle
2D proﬁles. The theoretical resolution is extendable to sub-nano-
meter, i.e. approaching high-resolution and indeed rather detailed
information has been obtained (Fig. 5, left). Smaller particles are
easily described, and remarkable results have been obtained char-
acterizing on- or off-pathway oligomers in various systems (e.g.Fig. 5. Examples of oligomeric structures obtained by different methods. Left: Scanning t
white box in the top panel and the surface topography along the white line. (Reprinted fr
H., ‘‘High resolution scanning tunnelling microscopy of the b-amyloid protein (Ab1–40) o
110,  2006 with permission from Elsevier.) Middle: SAXS-based solution structure of th
from decomposition of the data measured from the undisturbed equilibrium of the evolv
UV CD spectrum showing the high b-sheet content in the late fraction of gel-ﬁltrated oligo
Nowak, R.J., Walz, T., and Lansbury Jr., P.T. ‘‘a-synuclein, especially the Parkinson’s disea
1102,  2002 with permission from Elsevier.)[24,25]). One impressive example is the Ab-peptide oligomers
formed by apparent end-to-end associations, where what appears
to be individual b-strands are vaguely visible in protomers [24].
Such b-strand rich appearance would be expected for an on-path-
way oligomer, it is however not conclusive if the oligomers are
ﬁbril building blocks or not. Fully assembled ﬁbrils of elastin-de-
rived polypeptides have been characterized by AFM/STEM, reveal-
ing the overall, albeit lower-resolution features. Importantly, both
of the latter studies were performed without metalcoating of the
biological samples, which, apart from being highly desirable in
eliminating the risk of modifying the structures by the coating pro-
cess, also shows that at least the analysed ﬁbrils have interesting
charge-transfer properties. AFM may be used quantitatively (e.g.
[26,27]) or qualitatively. Qualitative AFM is often used in a semi-
time-resolved manner, examining the distribution of species dur-
ing the aggregation progress, e.g. compared under different solu-
tion conditions [28]. It may also be used in closed ﬂuid cells,
which enables in situ analysis of the structural effect of, e.g.
small-molecule compounds such as the example describing disag-
gregation of Ab-peptide oligomers [29] by small-molecules with
anti-cytotoxic effects in vivo. Hence, AFM is an important method
for direct time-resolved detection, e.g. of oligomer formation. Of
perhaps particular interest is the option to use biologically relevant
wetted surfaces, exempliﬁed by the primarily AFM-based study ofunneling microscopy of a single Ab1–40 oligomer, magniﬁcation corresponding to the
om J. Struct. Biol., 155, Losic, D., Martin, L. L., Mechler, A., Aguilar, M. I., and Small, D.
f Alzheimer’s disease suggests a novel mechanism of oligomer assembly”, pp. 104–
e insulin on-pathway structural nucleus. Reprinted from [4]. The model is obtained
ing ﬁbrillation. Right: Electron micrographs of A53T a-synuclein oligomers and far-
mers. (Reprinted from J. Mol. Biol., 322, Lashuel, H.A., Petre, B.M., Wall, J., Simon, M.,
se-associated mutants, forms pore-like annular and tubular protoﬁbrils”, pp. 1089–
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composition [30]. Surfaces play a signiﬁcant role on amyloid aggre-
gation propensity and kinetics [30–33], and on the resulting mor-
phologies of ﬁbrils, and all the above-mentioned techniques suffer
from extensive surface contact between specimen and sample sup-
port. Although the same applies to total internal reﬂection ﬂuores-
cence microscopy, this method is highly interesting since it allows
a time-resolved direct visualization of ﬁbril growth and branching
[18,34].5. Small angle scattering in solution
One major advantage when applying solution small angle neu-
tron or X-ray scattering (SANS/SAXS) to the study of amyloid for-
mation is exactly the lack of surface effects. Small angle
scattering (SAS) techniques are low-/medium resolution well-
established methods for the structural investigation of virtually
any type of particle on the nano-scale (resolves particles in the
range 1–100 nm). Relatively recent signiﬁcant improvements of
data analysis methods when applying SAXS/SANS to biological
solutions [35] have revitalized the ﬁeld, in particular by the devel-
opment of the elegant and appealing ab initio modelling methods
[36]. In combination with more traditional analysis such as the
derivation of overall dimensions, pair distance distribution func-
tions [37] and ﬁtting to known high-resolution structures [38]
potentially applying rigid-body modelling [39] provides structural
descriptions of biomacromolecules in solution quite complemen-
tary to other low-/medium-resolution methods (e.g. cryo-EM)
and high-resolution methods (e.g. X-ray crystallography). There
are virtually no limitations on the experimental conditions applied
and this is crucial in enabling studies of the amyloid process, since
particular conditions are necessary to promote ﬁbrillation. Of ut-
most importance, SAS data are additive, meaning that it is possible
to separate signals from one particular species in solution from a
collected signal, which may be exploited for kinetic studies of
ﬁbrillation. Accordingly, we used ab initio modelling based on
the SAXS data (Fig. 3, left) to describe the low-resolution three-
dimensional structure in solution of a co-occurring oligomeric
structural nucleus (Fig. 5, middle panel) and the repeating ﬁbril
unit of insulin [4] (Fig. 2, bottom). We revealed that an oligomeric
helical species consisting of approximately six protomers accumu-
lated in solution, and that its concentration directed the rate of ﬁ-
bril growth. In accordance, we proposed that this structural
nucleus was the building block of insulin ﬁbrils under the condi-
tions examined, and could suggest a mechanism of aggregation,
which would result in hollow tubular protoﬁlaments of a size
and molecular weight in accordance with the dimensions of the
mature ﬁbrils (Fig. 1) [4]. This would also imply that the structural
nucleus would be in a primarily b-sheet conformation, which again
suggested that almost the full length of the insulin backbone is re-
folded into b-strands, in accordance with e.g. CD and FTIR observa-
tions [40]. Our results were subsequently conﬁrmed by neutron
scattering experiments [41] and this work further debates the
aggregation mechanism involving these same structural nuclei.
Our current studies of both insulin ﬁbrillation under different
experimental conditions and other protein systems (Groenning
M. et al.; Giehm, L. et al., unpublished work) elaborate on the initial
ﬁndings, and further add to an understanding of ﬁbril formation
mechanisms but also reveal distinct differences in the overall con-
formation of different on-pathway oligomeric species. A recent
study of glucagon ﬁbrillation by Oliveira et al. [42] very elegantly
extends the method by using a completely model free approach
to isolate scattering fractions from the on-pathway intermediate
species. Also in this study, an oligomeric species is present in rela-
tively large quantity. The oligomer has an elongated shape, and theoverall dimensions were comparable to the insulin nucleus albeit
differing at more detailed level [42]. This is striking when taking
into account that the data are from two unrelated protein systems
with different native sequence, fold and oligomeric distribution.
The mature ﬁbrils were here described by ﬁtting rods, composed
of a high number of high-resolution native building-blocks, to
the SAXS data (Fig. 2 and [42]). On a related topic, spider silk ﬁ-
broin aggregation has been studied by a combination of SAXS, wide
angle X-ray scattering (WAXS) and Raman spectroscopy [43]. Here,
a microﬂuidic ﬂow cell where protein is mixed into a ﬂuid of lower
pH stimulating silk formation has been used. X-ray exposure at
increasing distance from the ﬂuid-cell mixing point corresponds
to increasing timepoints after initiation of ﬁber formation. Albeit
per deﬁnition not being an amyloid, the silk has a number of fea-
tures quite similar to that observed for amyloids (such as extensive
b-sheet formation perpendicular to the long axis of the ﬁber and an
overall large-scale aggregation via refolding), and also an elongated
pre-ﬁber structure of ﬁbroin is observed [43]. The study is men-
tioned here, in part for the resemblance of the results to the previ-
ously mentioned studies, in part for the microﬂuidic approach,
which may be of future use for studies of amyloid formation also,
although the foreseeable problems with clogging of the microﬂu-
idic channels need to be resolved. It is nevertheless of importance
to think in creative ways of preparing samples for structural stud-
ies of amyloid.
Several other studies report the use of SAXS or SANS for study-
ing various amyloid-related structural features. Most of them do
not go as far as actual ab initio modelling, but important conclu-
sions can still be reached based on the biophysical parameters de-
rived from the data. A few examples should be mentioned here.
One is the analysis of the early stages of a-synuclein ﬁbrillation,
where deconvolution of data based on two-state kinetics suggests
the formation of a preﬁbrillar heptamer [44], which in contrast to
the native unfolded state has a more globular appearance. This
study is combined with NMR-analysis, which pinpoints residues
seemingly involved in contacts during ﬁbrillation. In two other
studies, hen egg white lysozyme ﬁbrillation is studied by SAXS
and SANS [45,46], examining the effect of different experimental
conditions on the resulting ﬁbrillation state. Finally, an interesting
method, considering contributions to the data from polydisperse
systems, is the recent solution analysis of native Tau protein
[47], using the program Ensemble Optimization Method (EOM)
[48].
If applying SAS to analysis of the amyloid process, it is impor-
tant to carefully consider both the experimental conditions and
the data collection strategy. Although solution scattering data from
mixtures can be deconvoluted into the individual scattering curves,
this obviously only applies if it is possible to assign the accurate
number of individual states, and if each state is adequately repre-
sented in solution. Also, data from homogeneous solutions of one
or more of the individual states must be obtained or reliable
high-resolution structures as representative particles must be
available. Hence, starting conditions should always be very accu-
rately analysed, and it is very important that conditions evoke a
relatively homogeneous ﬁnal mature ﬁbril state also. The alterna-
tive is an analysis performed on data from averages of several
states, also after attempting deconvolution. This will in the best
case be meaningless, and in the worst case be directly misleading.
This warning speciﬁed, solution scattering offers a unique mean of
analysis of the amyloid process. The opportunity to obtain direct
structural data while experimental conditions can be ﬁne tuned
to the individual system (in contrast to being deﬁned by method-
ological limitations), that surface effects are negligible, and – in
particular – that the structural evolving equilibrium is left undis-
turbed during measurements, is not offered by any other structural
method.
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From the X-ray diffraction pattern of a single crystal (Fig. 3,
middle) the electron density, and thus the coordinates of all the
atoms can be determined, thereby attaining atomic resolution
structural information from the sample. The ultimate requirement
in X-ray crystallography is diffracting crystals, which in general
only forms from highly homogeneous solutions, which is not the
case for ﬁbrillating solutions. The resulting structural information
describing near-monolithic ‘snapshots’ of protein structure will
perhaps never adequately describe ﬁbrillar species, which in solu-
tion exist in dynamically changing equilibria between several
structural states. However, the high-resolution information that
has been obtained from amyloid-relevant systems is of immense
importance to our slowly improving understanding of the struc-
tural features underlying ﬁbrillation.
A large number of peptide fragments from ﬁbrillating proteins
have been studied theoretically to predict their ﬁbrillation propen-
sity. Subsequent experimental studies revealed numerous frag-
ments (typically 6–7 amino acids long) forming ﬁbrils with the
characteristic cross-b pattern. In addition some of these peptides
form nano- and microcrystals [49–51], which along with the
impressive development of high-quality micro/nano-focus beam-
lines [52,53] has enabled the structure determination of several
amyloidogenic peptides originating from a range of ﬁbrillating pro-
teins [49–51]. These structures reveal a high level of self-comple-
mentarity and also demonstrate a very tight packing of
neighbouring b-sheets in the so-called steric zipper (Fig. 4). The b-
sheets in these structures are straight, due to the crystal packing,
thus an open question is still how this relates to the twists and
intertwining of protoﬁlaments and mature ﬁbrils as observed by
AFM, STEM, etc. Even for such model peptides the comparison of
the structures in nano-crystals and the modelling of quasi-atomic
resolution structures onto ﬁbrils is not straight-forward [54]. Final-
ly, the position of the remaining polypeptide chains in the corre-
sponding full-length protein is impossible to predict, or even
imagine, based on the peptide structures. These problems, how-
ever, by no means reﬂect on a lack of importance or quality of
the high-resolution structures, on the contrary. The mentioned
problems only highlight the lack of information, which still domi-
nates the ﬁeld, and emphasizes the importance of struggling for
further advances of the same standard as these impressive
achievements. However difﬁcult to incorporate into full-length
models or mature ﬁbril structures, the high resolution crystal
structures do contribute to the understanding of the underlying
speciﬁc structural features and how differences in these features
may result in mature ﬁbrils with different morphologies. In the
peptide structures motifs with parallel in-register arrangement of
the b-strands appear to dominate [50,55].
The peptide structures have been used for modelling onto low-
er-resolution structures [11,12]. Some ambiguity obviously re-
mains in such approaches, but these studies are perhaps
examples of a useful future approach. It seems highly relevant to
combine several structural methods with different resolution and
experimental restrictions, such as to bridge from high-resolution
structures, e.g. of isolated fragments, to low-resolutions structures
of mature ﬁbrils or other on- and off-pathway species. As an exam-
ple, the insulin structural nucleus described based on SAXS-data
[4] has an overall structure and dimensions that indicate that most,
if not all, of the protein must form b-strands (see [4] for details). At
present, it is not possible to map the high-resolution structures of
insulin-fragments [49] onto the structural nucleus in any meaning-
ful way, on the contrary, the two studies to a certain extent are
contradictory. However, if a structural nucleus is formed in solu-
tions of ﬁbrillating peptides, and if this structural nucleus indeedis on-pathway, then the conformation of individual peptides with-
in the nucleus should be related to the crystal structure
conformations.
Structural information of the ﬁbril state is available through
ss-NMR as described very well by Heise [56]. In ss-NMR the 1H
signals are not observable, thus 15N and 13C labeling is necessary,
which can be difﬁcult to obtain for larger recombinant proteins,
but the labeling has advantages. Dividing the labeling can be uti-
lized in the segmented assignment strategy [57] and labeling can
also be exploited to distinguishing between parallel and anti-par-
allel arrangement of the b-strands through single site labeling
[58,59]. Distances between single sites of 4.7–5 Å can only be ful-
ﬁlled in the parallel in-register b-strand arrangement, whereas
longer distances must be combined with additional constraints
to separate off-register and anti-parallel arrangements. Thus the
method can also uncover the (approximate) registry of the b-
strands, and along with distance restrains elucidate the molecular
arrangements and motifs at a fairly detailed level. Polymorphism
of ﬁbrils is believed to be caused by underlying differences of the
packing at molecular level, and thus the different forms will be
distinguishable by NMR as shown for Ab by Petkova and co-work-
ers [60].
ss-NMR studies have also enabled direct comparison of peptide
nano-crystals and ﬁbrils [54]. For one of the published peptide zip-
per crystal structures (sequence GNNQQNY) three co-existing
ﬁbrillar forms were found (or three structural conformations co-
existing in one ﬁbril) along with the two known crystal forms
[49,50]; detailed comparison of individual chemical shifts and
Tyr-Tyr interactions reveal several differences, thus also exempli-
fying the complexity of correlating crystal structures and ﬁbrils
even for the model peptides. Valuable information on the ﬁbrillar
core region of full-length proteins as obtained for a-synuclein
[59] is an excellent example of the type of information required
in the complex puzzle of correlating peptide fragment high-resolu-
tion structures to the low-resolution information from the corre-
sponding full-length proteins. Solution NMR has provided high-
resolution structures of partially re-folded monomers, which how-
ever are clearly not in a signiﬁcantly refolded b-sheet rich confor-
mation directly relevant for ﬁbril formation [61]. Solution NMR can
also complement ss-NMR with information on solvent accessibility
through H/D exchange experiments revealing buried hydrogen
bond interactions. A very ﬁne example of the results of a joint solu-
tion and ss-NMR study is the Ab structure [62]. For transthyretin
(TTR) the solvent accessibility of the ﬁbrils were compared with
the native TTR crystal structure resulting in a proposed model of
the TTR ﬁbrils with TTR retaining a native-like structure in the ﬁ-
brils [63] (Fig. 4, bottom). Ss-NMR may also successfully be com-
bined with other methods, e.g. with ﬁber diffraction, TEM and
AFM as in the case of the de novo designed ccb peptide [64] or with
mutational studies as for a domain of a human transcriptional acti-
vator [65].
X-ray crystallography or solution NMR can also be employed to
obtain relevant information of native and native-like structures,
e.g. the complex of prion protein and RNA [66], a domain-swapped
Rnase A [67], Tau protein [68] and acylphosphatase from Sulfolobus
solfataricus [69].
In conclusion, the high-resolution methods all provide extre-
mely important information on the details of the ﬁbril structure.
These methods will remain of utmost importance in the amyloid
ﬁeld, in spite of the signiﬁcant associated challenges. In particular,
high-resolution methods are crucial for obtaining the atomic coor-
dinates revealing not only the structures themselves, but also
potentially their interactions with speciﬁc amyloid probes (such
as the ﬂuorophores thioﬂavin T (ThT) or congo red) or potential
small-molecule or peptide based inhibitors of ﬁbrillation.
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Several techniques offer complementary indirect structural
information. Structural models based on any of the mentioned
techniques have limitations, thus for increased validation and
application it is important to use additional information. This can
be done by combining low- and high-resolution methods, and/or
by correlating with indirect complementary methods. Here we will
mention a few of the most relevant complementary methodologies
in the ﬁeld of amyloid structure, but a full list of the many tech-
niques applied is beyond the scope of this minireview. Changes
in secondary structure content can be followed through CD during
the ﬁbrillation process (Fig. 3). An example is the study of the
kinetics of Concanavalin A by Vetri et al. [70] where AFM and
ThT ﬂuorescence measurements are also employed. Several varia-
tions of Raman spectroscopy and microscopy are also applied in
the study of amyloids. Multiple examples of FT-IR approaches used
in the analysis of amyloids are described in the review by Hirama-
tsu and Kitagawa [71]. The study of amyloids also beneﬁts from ad-
vances within the ﬁeld such as the use of drop-coating-deposition-
Raman [72]. In addition RAMAN microscopy is used in post mortem
studies of amyloid deposits formed in the brain of human and, e.g.
for in vitro characterization of a-synuclein ﬁbrillation [73] (and
references herein).
Other interesting methods providing information on the ﬁbrilla-
tion process and species are, e.g. neutron reﬂectometry in which
important molecular interactions are elucidated by studying
interactions of the ﬁbrillating proteins with various charged lipid
membranes [74] and ultrasound velocimetry, densimetry and cal-
orimetry along with FTIR was used in a study of insulin ﬁbrillation
[75].
8. Modelling
The application of theoretical calculations and modelling to an-
swer questions relating to ﬁbrils and the ﬁbrillation process spans
widely from all atom molecular dynamic simulations studying the
speciﬁc interactions involved between peptides, over larger scale
simulations of the ﬁbril formation to the prediction of ﬁbrillation
propensity from a given amino acid sequence.
Many different approaches have been employed to obtain the
latter information. Several of these methods rely on structural
information either from proteins in general [76] or have been
based on speciﬁc structural motifs (e.g. parallel b-strands) (Fig. 4)
[77–79]. The selection of sequences for the peptide crystal struc-
tures is an example of the success of this approach.
Some fundamental features of ﬁbrillation make the application
of existing modelling approaches quite complex: the ﬁbrils are in a
local minimum in the energy landscape, whereas the nucleus per
deﬁnition is the thermodynamically least favorable species in the
process. This complicates the theoretical work on describing the
early stages of the ﬁbrillation process, as these features per deﬁni-
tion are up-hill in energy terms. Another problem complicates the-
oretical calculations: Most methods use experimental high-
resolution structures as a starting point of simulations. There is
however an, enormous gap in knowledge between structures of
the native state of several ﬁbrillation-prone proteins and the
above-mentioned structures of isolated peptides in an amyloid-rel-
evant conformation.
Simulations and predictions are still very important tools in
identifying, e.g. signiﬁcant energy contributions, intermolecular
interactions as well as explaining (or predicting) oligomer sizes.
All atom simulations are the most accurate calculations, but
also the most CPU demanding and thus only relatively short time
frames (typically nanosecond scale) are simulated. These types ofcalculations require a starting molecular geometry and therefore
beneﬁt from using crystal or NMR structures as starting points.
The method can pinpoint important native interactions and evalu-
ate the energy involved in a given refolding process marking the
starting point of ﬁbril formation. A simulated disaggregation of
the GNNQQNY zipper [80] is an example of the use of crystal struc-
tures, studying the stability of the structure in a reverse manner.
Larger scale simulations using simpliﬁed peptide models (‘‘inter-
mediate resolution”) have been employed to study aggregation of
a ﬁnite number of model peptides [81], which evaluated different
ﬁbril growth mechanisms.
An interesting example of all-atom modelling is the ccb peptide
(17 residue de novo synthesized peptide, [82]) where the free en-
ergy landscape was surveyed to ﬁnd several local minima for struc-
tures containing three b-strands. Hence, even for this relatively
small peptide several pathways from the native-like coiled-coiled
structure could be found, highlighting the complexity of these sys-
tems. The latter study elegantly demonstrates the fundamental
problems associated with modelling without experimental data,
and at the same time holds promise for the application of advanced
modelling, once relevant high-quality data of individual states, or a
limited number of states, is available.
Even modelling a limited number of states, described via high-
quality experimental data, is troublesome. Perhaps one particular
class of development is of the greatest need within modelling of
ﬁbrillation, namely ensemble modelling. Fibrillation is in essence,
at any timepoint, an evolving equilibrium of different structures,
and in order to describe intermediate states adequately, it is
important to consider ensembles of structures. It is important to
objectively estimate the correct number of structures in such an
ensemble, when ﬁtting to data. Too few structures will result in
underﬁtting (relevant conformations are missing even if the result
ﬁts to the data), while too many structures will result in overﬁtting
(one is essentially modelling noise, which will improve the ﬁt, but
not include meaningful structures).
In SAXS, the data can be deconvoluted using singular valued
decomposition or simply by applying the lowest possible number
which will adequately describe the data. This was successfully
applied in the previously mentioned amyloid studies [4,41,42].
Another approach is to select a given number of structures from
a pool of plausible structures, and ﬁt a linear combination of
such structures to the data curves, e.g. as is done in the program
EOM, developed for SAXS and NMR [48]. Neither singular value
decomposition nor EOM addresses the problem of selecting the
optimal number of structures in a statistically fully adequate
way.
As a ﬁnal mentioning: the large-scale conformational changes
involved with initial refolding limits the usefulness of molecular
dynamics simulations, partly due to computational limitations.
Rather, future improved ab initio protein structure prediction
methods may prove to be adequate for modelling of the refolded
amyloid state.
9. Outlook
Above, many of the limitations and challenges by applying dif-
ferent structural methods have been mentioned. Various ap-
proaches may be applied in order to overcome the difﬁculties. A
few suggestions should be summarized here. Firstly, the combina-
tion of several structural methods is appropriate, in order to com-
pensate for the shortcomings of one method by the inclusion of
another. Importantly, SAXS/SANS based ab initio models from
time-resolved analysis must be included when combining high-
and low-resolution methods. These structures are highly comple-
mentary in nature to those obtained from crystallography,
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be a linkage between several other methods.
The emerging technique of time-resolved wide angle X-ray
scattering [83] could potentially be of interest also for ﬁbrillation
studies, although several technical problems need to be solved
ﬁrst. Such data are a prime example of the need for an improved
modelling methodology, including true ab initio methods on
ensembles of proteins, a need already signiﬁcant when dealing
with non-amyloid systems [83] and assumingly even more pro-
nounced with the large structural conversions expected in
ﬁbrillation.
A particular challenge in the ﬁeld is in vivo characterization.
Comparative studies of in vitro and in vivo generated ﬁbrils is
one step, but with time more radical approaches are needed such
as, e.g. the NMR structure determination recently demonstrated
from living cells [84] or the challenging and promising tomogra-
phy, e.g. reviewed by Nordberg [85]. However manifold the chal-
lenges, they are signiﬁcantly outnumbered by the needs and
interests in obtaining further structural understanding. There is
signiﬁcant interest within research ﬁelds spanning from basic sci-
ence to drug development and materials design, hence there is a
natural drive within the community towards obtaining future re-
sults even more impressive than what has already been pointed
out here.
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